Literature DB >> 10748619

Stability of L-asparaginase: an enzyme used in leukemia treatment.

A L Stecher1, P M de Deus, I Polikarpov, J Abrahão-Neto.   

Abstract

L-asparaginase from Escherichia coli is an important enzyme widely used in leukemia treatment under the trade name Elspar. Up to now, however, the aspects of its stability and storage has not been studied in detail. The aim of this work is to analyze the factors that could interfere in the enzyme's stability. The enzymatic activity was found to be stable in wide pH range (4.5-11.5), showing a slight increase in activity and stability in alkaline pHs, which indicates a more stable conformation of the molecule. The enzyme proved to have a high activity restoration capacity when submitted to temperatures of 65 degrees C, in pH 8.6 buffer and, surprisingly, in physiologic solution. This suggests a positive effect of sodium ions on such restoration capacity. Stability was high in different diluents used as parenteral solutions and in recipients used in medical practice without significant loss of activity for at least 7 days. These results lead us to conclude that the enzyme has a high stability after the lyophilized form has been reconstituted (at least 7 days), since the necessary precautions are taken in terms of sterile manipulation and if it is stored in a suitable parenteral vehicle under low temperature (about 8 degrees C).

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10748619     DOI: 10.1016/s0031-6865(99)00009-6

Source DB:  PubMed          Journal:  Pharm Acta Helv        ISSN: 0031-6865


  13 in total

1.  Therapeutic enzyme deimmunization by combinatorial T-cell epitope removal using neutral drift.

Authors:  Jason R Cantor; Tae Hyeon Yoo; Aakanksha Dixit; Brent L Iverson; Thomas G Forsthuber; George Georgiou
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-05       Impact factor: 11.205

2.  Human 60-kDa lysophospholipase contains an N-terminal L-asparaginase domain that is allosterically regulated by L-asparagine.

Authors:  Christos S Karamitros; Manfred Konrad
Journal:  J Biol Chem       Date:  2014-03-22       Impact factor: 5.157

3.  Elucidation of the specific function of the conserved threonine triad responsible for human L-asparaginase autocleavage and substrate hydrolysis.

Authors:  Julian Nomme; Ying Su; Arnon Lavie
Journal:  J Mol Biol       Date:  2014-04-22       Impact factor: 5.469

4.  Multi level statistical optimization of l-asparaginase from Bacillus subtilis VUVD001.

Authors:  Rajeswara Reddy Erva; T C Venkateswarulu; Bangaraiah Pagala
Journal:  3 Biotech       Date:  2017-12-19       Impact factor: 2.406

Review 5.  Overview of the structure, side effects, and activity assays of l-asparaginase as a therapy drug of acute lymphoblastic leukemia.

Authors:  Nanxiang Wang; Wenhui Ji; Lan Wang; Wanxia Wu; Wei Zhang; Qiong Wu; Wei Du; Hua Bai; Bo Peng; Bo Ma; Lin Li
Journal:  RSC Med Chem       Date:  2022-01-12

6.  Optimization of Culture Conditions for Production of the Anti-Leukemic Glutaminase Free L-Asparaginase by Newly Isolated Streptomyces olivaceus NEAE-119 Using Response Surface Methodology.

Authors:  Noura El-Ahmady El-Naggar; Hassan Moawad; Nancy M El-Shweihy; Sara M El-Ewasy
Journal:  Biomed Res Int       Date:  2015-06-09       Impact factor: 3.411

7.  Cloning, expression, purification and characterisation of Erwinia carotovora L-asparaginase in Escherichia coli.

Authors:  Meraj Pourhossein; Hassan Korbekandi
Journal:  Adv Biomed Res       Date:  2014-02-28

8.  Enhanced stability of L-asparaginase by its bioconjugation to poly(styrene-co-maleic acid) and Ecoflex nanoparticles.

Authors:  Jaleh Varshosaz; Negin Anvari
Journal:  IET Nanobiotechnol       Date:  2018-06       Impact factor: 1.847

9.  E. coli-Derived L-Asparaginase Retains Enzymatic and Cytotoxic Activity In Vitro for Canine and Feline Lymphoma after Cold Storage.

Authors:  Jackie M Wypij; Holly C Pondenis
Journal:  Vet Med Int       Date:  2013-04-28

10.  Purification, characterization, cytotoxicity and anticancer activities of L-asparaginase, anti-colon cancer protein, from the newly isolated alkaliphilic Streptomyces fradiae NEAE-82.

Authors:  Noura El-Ahmady El-Naggar; Sahar F Deraz; Hoda M Soliman; Nehal M El-Deeb; Sara M El-Ewasy
Journal:  Sci Rep       Date:  2016-09-08       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.